Dis-Chem Pharmacies Beheer
Beheer criteriumcontroles 4/4
De CEO Dis-Chem Pharmacies is Rui Morais, benoemd in Jul2023, heeft een ambtstermijn van 1.33 jaar. De totale jaarlijkse vergoeding van { bedraagt ZAR 16.70M, bestaande uit 74.8% salaris en 25.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.99% van de aandelen van het bedrijf, ter waarde ZAR 321.45M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.3 jaar en 3.8 jaar.
Belangrijke informatie
Rui Morais
Algemeen directeur
R16.7m
Totale compensatie
Percentage CEO-salaris | 74.8% |
Dienstverband CEO | 1.3yrs |
Eigendom CEO | 1.0% |
Management gemiddelde ambtstermijn | 2.3yrs |
Gemiddelde ambtstermijn bestuur | 3.8yrs |
Recente managementupdates
Recent updates
These 4 Measures Indicate That Dis-Chem Pharmacies (JSE:DCP) Is Using Debt Reasonably Well
Aug 21Shareholders Should Be Pleased With Dis-Chem Pharmacies Limited's (JSE:DCP) Price
Jun 06Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around
Apr 17Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly
Feb 26Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively
Dec 30If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity
Sep 07Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly
Aug 16Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends
Jul 31Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?
May 09There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital
Mar 29Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?
Jan 14Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture
Nov 04Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate
Oct 04We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease
Sep 01Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital
Jul 04A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)
Jun 21Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet
Jun 08The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts
May 25Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?
Feb 23Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings
Feb 08I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease
Dec 13Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality
Nov 09Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Aug 31 2024 | n/a | n/a | R1b |
May 31 2024 | n/a | n/a | R1b |
Feb 29 2024 | R17m | R12m | R984m |
Nov 30 2023 | n/a | n/a | R942m |
Aug 31 2023 | n/a | n/a | R899m |
May 31 2023 | n/a | n/a | R949m |
Feb 28 2023 | R18m | R12m | R1b |
Nov 30 2022 | n/a | n/a | R1b |
Aug 31 2022 | n/a | n/a | R1b |
May 31 2022 | n/a | n/a | R946m |
Feb 28 2022 | R14m | R11m | R853m |
Nov 30 2021 | n/a | n/a | R815m |
Aug 31 2021 | n/a | n/a | R776m |
May 31 2021 | n/a | n/a | R722m |
Feb 28 2021 | R6m | R6m | R669m |
Nov 30 2020 | n/a | n/a | R655m |
Aug 31 2020 | n/a | n/a | R641m |
May 31 2020 | n/a | n/a | R620m |
Feb 29 2020 | R6m | R6m | R598m |
Nov 30 2019 | n/a | n/a | R573m |
Aug 31 2019 | n/a | n/a | R549m |
May 31 2019 | n/a | n/a | R634m |
Feb 28 2019 | R5m | R5m | R719m |
Nov 30 2018 | n/a | n/a | R718m |
Aug 31 2018 | n/a | n/a | R718m |
May 31 2018 | n/a | n/a | R701m |
Feb 28 2018 | R7m | R5m | R684m |
Compensatie versus markt: De totale vergoeding ($USD 964.89K ) Rui } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de ZA markt ($USD 1.41M ).
Compensatie versus inkomsten: De vergoeding van Rui is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Rui Morais (40 yo)
1.3yrs
Tenure
R16,702,000
Compensatie
Mr. Rui Manuel Morais, CA(SA) has been the Chief Executive Officer at Dis-Chem Pharmacies Limited since July 01, 2023 and its Executive Director since August 13, 2012. He served as Chief Financial Officer...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO & Executive Director | 1.3yrs | R16.70m | 0.99% ZAR 321.4m | |
CFO & Executive Director | 1.3yrs | R5.19m | geen gegevens | |
Executive Director | 1.4yrs | R18.45m | geen gegevens | |
Managing Director | 19.5yrs | R14.97m | geen gegevens | |
Executive Director | 2.3yrs | R7.56m | 0.79% ZAR 255.0m | |
Executive Director | 2.3yrs | R7.58m | 4.65% ZAR 1.5b | |
Prescribed Officer | no data | R7.81m | geen gegevens | |
Commercial Director | no data | R15.38m | 0.0045% ZAR 1.5m | |
Prescribed Officer | no data | R4.61m | 0.0012% ZAR 379.8k | |
Prescribed Officer | no data | R5.11m | geen gegevens | |
Human Resources Director | no data | geen gegevens | geen gegevens | |
Company Secretary | 3.7yrs | geen gegevens | geen gegevens |
2.3yrs
Gemiddelde duur
67yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van DCP wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.3 jaar).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO & Executive Director | 12.3yrs | R16.70m | 0.99% ZAR 321.4m | |
CFO & Executive Director | 1.3yrs | R5.19m | geen gegevens | |
Executive Director | 19.5yrs | R18.45m | geen gegevens | |
Executive Director | 2.3yrs | R7.56m | 0.79% ZAR 255.0m | |
Executive Director | 2.3yrs | R7.58m | 4.65% ZAR 1.5b | |
Independent Non-Executive Chairman | 8.1yrs | R3.34m | 0.058% ZAR 18.9m | |
Independent Non-Executive Director | 8.1yrs | R967.00k | 0.0095% ZAR 3.1m | |
Independent Non-Executive Director | 8.1yrs | R691.00k | 0.019% ZAR 6.1m | |
Independent Non-Executive Director | 3.8yrs | R750.00k | geen gegevens | |
Non-Independent Non Executive Director | 3yrs | R560.00k | geen gegevens | |
Independent Non-Executive Director | 2.3yrs | R788.00k | geen gegevens |
3.8yrs
Gemiddelde duur
53.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van DCP wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).